Immune Checkpoint Inhibitors in Lung Cancer Immune Checkpoint Inhibitors in Lung Cancer

The PD-1, PD-L1, and CTLA-4 inhibitors show promise in lung cancer, but questions about biomarker use and place in therapy need to be resolved.Chinese Clinical Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news